Featured News
When we first featured the story of Bruno and his mission to complete a half-ironman while battling stage III melanoma, it struck a chord with many of our members and followers.
Australia and The Netherlands have an alarming statistic in common – melanoma is in their top five most diagnosed cancers. Clinical teams from both countries are now contributing to the international MelMarT-II trial.
As a retired primary school teacher, Viv has spent most of his adult life passing on valuable knowledge to his students. But it was a visit to his doctor that provided him with an unexpected – and lifesaving – lesson.
A community fundraising campaign has donated $100,000 to a clinical trial investigating melanoma that has spread to the brain.
MASC Trials and Melanoma Patients Australia have launched Self-Skin Checks, No Regrets, an Australian first campaign targeting rural and regional Australians 60+ to regularly check their skin.
An Australian-led trial is now gathering melanoma experts from around the world to contribute results from 3,000 patients to determine the optimal surgical excision margin for melanoma of the skin.
Leading Merkel cell carcinoma expert, Dr Wen Xu, recently presented two Australian clinical trials at the 2nd International Symposium of Merkel Cell Carcinoma in Seattle, USA.
The I-MAT clinical trial is giving patients with early-stage Merkel cell carcinoma an immunotherapy drug after their initial surgery and / or radiotherapy for the cancer to improve their cure rates.
Morgan Mansell passed away from melanoma when she was just 25 years old. Her legacy lives on through the Morgan Mansell Fund, which supports melanoma research, and her writing.
A new innovative clinical trial hopes to find a novel treatment combination for patients who have developed metastatic Merkel cell carcinoma.